​

Funding Round

Venture Round - Millendo Therapeutics

Venture Round - Millendo Therapeutics

Investment Firm

Overview

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.

Announced Date

Aug 09, 2018

Closed on Date

Aug 30, 2018

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorRoche Venture Fund
Participant InvestorAdams Street Partners
Participant InvestorFrazier Healthcare Partners
Participant InvestorOUP (Osage University Partners)
Participant InvestorNew Enterprise Associates

Round Details and Background

Millendo Therapeutics raised $30000000 on 2018-08-09 in Venture Round

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2020
Post-IPO Equity - Millendo Therapeutics
-50.0M
Jan 05, 2016
Series B - Millendo Therapeutics
9-62.0M
Feb 26, 2013
Private Equity Round - Millendo Therapeutics
-8.5M
Aug 03, 2012
Series A - Millendo Therapeutics
4-16.0M

Recent Activity

There is no recent news or activity for this profile.